GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com


Jump to: navigation, search

Lamy, ME, Favart, AM, Cornu, C, Salizzoni, M, Cimadamore, N, de Hemptinne, B and Otte, JB (1990) Epstein-Barr virus infection in 59 orthotopic liver transplant patients. Med. Microbiol. Immunol. 179:137-44


Fifty-nine orthotopic liver transplant (OLT) patients were studied after transplantation to detect Epstein-Barr virus (EBV) primoinfection and reactivation. Nineteen, all children under 10 years, were EBV seronegative. Seroconversion occurred in 12 (63.3%) of the seronegative patients. Most of these patients (10/12) seroconverted 2 or 3 months after transplantation; 11 out of the 12 demonstrated clinical signs at the time of seroconversion. From 9 primoinfected patients tested for EBV excretion, 8 were found to be positive. Serological evidence of reactivation was found in 9 out 40 (22.5%) seropositive patients and EBV was isolated from 5 (56%). Eleven pediatric OLT patients with primoinfection showed high and persistent titers of anti-EA antibodies (from 1:32 to greater than or equal to 1:256), when tested at least 3 months after seroconversion; however, anti-EBNA antibodies failed to develop in 5 patients and remained persistently low in 4. These patients with high EA and with negative or low EBNA titers constitute an "at risk" group for EBV-related lymphoproliferative syndrome (LpS). At presently, after a period of follow-up ranging from 3 months to 3 years, none of our 12 primoinfected patients have developed any lymphoproliferative evolution. However, in 1, during the acute phase, lymphoblasts and lymphoproliferation were observed in a tonsil biopsy.




Acute-Phase Proteins/immunology; Adolescent; Adult; Antibodies, Viral/analysis; Antigens, Viral/analysis; Child; Child, Preschool; Herpesvirus 4, Human/growth & development; Herpesvirus 4, Human/immunology; Herpesvirus 4, Human/isolation & purification; Humans; Infant; Liver Transplantation/adverse effects; Virus Activation/immunology



Gene product Qualifier GO Term Evidence Code with/from Aspect Extension Notes Status

See also


See Help:References for how to manage references in GONUTS.